Richard Pascoe takes the helm at Histogen; Lonza COO steps up at CEO Richard Ridinger retires
→ Having handed off troubled microcap biotech Apricus Biosciences to Seelos Therapeutics via a merger, Richard Pascoe
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
